Monclip FX Suspension is a combination of Montelukast (4mg/5ml) and Fexofenadine (60mg/5ml), formulated for effective relief from respiratory allergies, allergic rhinitis, and seasonal allergy symptoms. Montelukast, a leukotriene receptor antagonist (LTRA), works by reducing inflammation and preventing asthma-related allergic reactions. Fexofenadine, a non-sedating antihistamine, blocks histamine action, providing long-lasting relief from sneezing, runny nose, and itching.
This suspension is suitable for pediatric and adult patients needing targeted allergy relief without drowsiness. It is a trusted option in managing asthma-related allergies, chronic urticaria, and hay fever.
While Monclip FX Suspension is generally well-tolerated, some individuals may experience mild to moderate side effects, including: Common Side Effects: Headache, drowsiness, dizziness, dry mouth, nausea, and stomach discomfort. Rare but Serious Side Effects: Increased heart rate, severe allergic reactions (rash, swelling, difficulty breathing), mood changes, or liver dysfunction. If any severe side effects occur, seek immediate medical attention.
This suspension is primarily indicated for the treatment of allergic rhinitis, hay fever, pollen allergies, and chronic urticaria (hives). It also helps in managing respiratory allergies and asthma-related allergic reactions. It effectively reduces nasal congestion, sneezing, and itchy or watery eyes caused by environmental allergens.
Fexoform M Suspension should be taken as prescribed by a healthcare professional. Avoid exceeding the recommended dose. Patients with severe asthma or liver issues should consult a doctor before use.
Store Monclip FX Suspension at room temperature (below 30°C) in a dry place, away from direct sunlight and moisture. The bottle should be kept tightly closed to prevent contamination. Do not freeze the suspension, and ensure it is stored out of reach of children.